2023 | Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial | Kelley, Robin Kate; Ueno, Makoto; Yoo, Changhoon; Finn, Richard S; Furuse, Junji; Ren, Zhenggang; Yau, Thomas; Klümpen, Heinz-Josef; Chan, Stephen L; Ozaka, Masato; Verslype, Chris; Bouattour, Mohamed; Park, Joon Oh; Barajas, Olga; Pelzer, Uwe; Valle, Juan W; Yu, Li; Malhotra, Usha; Siegel, Abby B; Edeline, Julien; Vogel, Arndt; CHIUN HSU | Lancet (London, England) | 111 | | |